Entero Therapeutics Stock Price, News & Analysis

Entero Therapeutics (NASDAQ:ENTO) said its subsidiary Grid AI is finalizing a U.S.-based leadership team to accelerate a major U.S. expansion of its AI-ready digital infrastructure and orchestration technology.

The company expects to name a U.S. CEO and Executive Chairman soon and cites leadership with public-markets experience in demand-response and energy-flexibility. Grid AI highlights industry demand signals including $60B of new AI-data-center projects announced in the past 90 days, AMD's projection of a $1T data-center market by 2030, and a need for >2,000 new data centers worldwide.

Entero says it has invested $50M since 2019 to develop the platform and will provide further updates on appointments and U.S. expansion in the coming weeks.

Entero (NASDAQ:ENTO) announced a Letter of Intent to integrate LV Grid's engineering team and IP into its Grid AI subsidiary to expand into the hyperscaler AI data-center energy-orchestration market.

The combined team will develop an AI Data Center Controls division and deliver a digital-dispatch and campus-optimization engine, starting with a flagship AI data-center energy park in Texas. Management highlighted potential recurring software revenues and optimization fees from hyperscaler customers.

Entero cited Goldman Sachs estimates of ~50 GW incremental hyperscale power demand by 2028–2030, $300–600 billion in build-out costs, and a $10–20 billion addressable market for next-generation optimization platforms.

Entero (NASDAQ: ENTO) announced the acquisition of GRID AI on October 30, 2025, a move that shifts the company from biotech toward grid-edge AI and energy orchestration.

Key facts: GRID AI reportedly represents more than $50 million and years of engineering investment, includes products like Dynamic Load Shaping™ and an Aggregation Management Platform, and claims to coordinate distributed assets (EV chargers, solar, HVAC, batteries). The deal restored Entero's Nasdaq compliance and leverages a compact capital structure (<2.5 million shares outstanding) to concentrate potential upside.

Entero Therapeutics (NASDAQ:ENTO) announced on October 30, 2025 that it acquired 100% of Grid AI Corp., has made Grid AI a wholly owned subsidiary, and has regained compliance with Nasdaq Listing Rule 5550(b)(1). The company describes its platform as positioned at the intersection of AI, hyperscale data centers, power grids and global infrastructure to pursue grid-edge orchestration and AI-driven infrastructure optimization.

The release also notes forward-looking statements and specifically references the need to obtain shareholder approval for common stock underlying preferred stock issued in the acquisition and uncertainty about future results.

Entero Therapeutics (NASDAQ:ENTO) launched Grid AI Corp. on October 16, 2025 to coordinate AI data center compute with electric grids. The company says rising AI demand will push global data center electricity beyond 1,000 TWh and that AI workloads account for over 30% of that growth, requiring more than $1 trillion in new energy and digital infrastructure investment.

Grid AI's platform claims to orchestrate and dispatch flexible data center loads in real time, unlocking stranded capacity, shortening interconnection timelines, and enabling participation in demand-response and ancillary markets. Analysts cited estimate flexible capacity (5–10%) could free >100 GW, accelerate deployments by up to 24 months, and create a $150–$200 billion annual addressable market for software and controls.

Entero Therapeutics (NASDAQ:ENTO) announced a strategic pivot by acquiring GRID AI, moving from biotech toward grid orchestration technology focused on behind-the-meter assets.

The deal highlights a $2.5 billion target market cited to quadruple by 2033, a platform built with more than $50 million of engineering investment, and a Dynamic Load Shaping and Aggregation Management Platform for EV chargers, rooftop solar, HVAC and batteries.

Post-transaction, GRID AI stakeholders hold more than 80% of Entero equity and the company has 1.69 million fully diluted shares, positioning the microcap to play in AI-driven energy orchestration.

Entero Therapeutics (NASDAQ:ENTO) announced a strategic transformation by acquiring GRID AI on October 14, 2025, repositioning the company from biotech to grid-edge energy orchestration.

Key facts: GRID AI has absorbed over $50 million of investment since 2019; the grid-edge sector cited is ~$2.5 billion; GRID AI shareholders will own >80% of Entero on a fully diluted basis, and Entero reports 1.69 million fully diluted shares.

The release frames the deal as a move to provide Dynamic Load Shaping and Aggregation Management for distributed assets (solar, EV chargers, HVAC) to address AI-driven energy demand; risks named include utility caution, regulatory friction, and multi-jurisdiction scaling challenges.

Entero Therapeutics (NASDAQ:ENTO) has announced a transformative acquisition of GRID AI Corp, positioning itself in the rapidly growing AI energy-infrastructure market. GRID AI's platform utilizes AI and machine learning to manage distributed energy resources and balance power supply and demand in real-time.

The deal structure gives GRID AI shareholders 82.5% ownership of ENTO's fully diluted common stock, while existing ENTO shareholders retain 17.5%. GRID AI's technology addresses the surging power demands from AI data centers, with Goldman Sachs projecting global data-center power demand to increase ~50% by 2027 and up to 165% by 2030 versus 2023 levels.

The acquisition leverages over $50 million invested in GRID AI since 2019, targeting a market expected to see AI infrastructure investments exceeding $2.8 trillion by 2029.

Entero Therapeutics (NASDAQ: ENTO) has announced the acquisition of GRID AI Corp, a grid-edge AI platform company, marking a strategic pivot into the AI energy infrastructure market. GRID AI's platform, which has received over $50 million in investment since 2019, specializes in Dynamic Load Shaping and Aggregation Management for behind-the-meter energy assets.

The transaction structure will result in GRID AI shareholders owning 82.5% of ENTO's fully diluted common stock, while existing ENTO shareholders will retain 17.5%. The deal includes board restructuring, with GRID AI shareholders initially appointing two directors and eventually controlling five of seven board seats.

This strategic acquisition positions ENTO in a high-growth market, as Goldman Sachs projects global data-center power demand to increase by ~50% by 2027 and up to 165% by 2030 versus 2023 levels, driven by AI infrastructure expansion.